- FAQs – on Glycerin - November 21, 2020
- FAQs on Pollution in Drug, Cosmetics & Homeopathic Industries - November 9, 2020
- FAQs – on Drug Permission in Brand or Generic Name - October 23, 2020
Q1: Who will issue license for manufacturing of Narcotic drugs?
Ans: Excise and Taxation department will issue Narcotic license to the manufacturer on Form 24 on the recommendation of State Drugs Controller.
Q2: Who will issue sale license to the chemist shops for sale of Narcotic drugs?
Ans: Excise and Taxation department will issue Narcotic license to the chemist shop on Form 25 on the recommendation of State Drugs Controller.
Q3: Whether the nursing homes required license for stocking Narcotic drugs?
Ans: Yes, in the form of RMI (Registered Medical Institute) certificate issued by State Drugs Controller in which six drugs has been notified which come under this certificate.
Q4: What are the new guidelines regarding Brand Name permissions to the manufacture for allopathic drugs?
Ans: As per Govt. notification no. 828(E) dated 06.11.2019, the allopathic drug manufacturer if wants to manufacture drugs by brand name then he should submit Form-51 to the concerned State Drug Controller.
To download the notification, click here
Q5: Is any fee/challan form required for taking permission?
Ans: No. If the firm is already having permission of the drug in generic then there is no need of extra fee.
Q6: What is the status of Tramadol salt?
Ans: This drug comes under NDPS Act as psychotropic substances on dated 26.04.2018.
Q7: What is status of combination of Buprenorphine+Naloxone sublingual tablets?
Ans: These tablets are covered under NDPS Act, official in USP 2018. This preparation can be supplied to psychiatric clinics and hospitals in addition to de-addiction centres as per latest DCG(I)’s letter dated 28.03.2019.
For more FAQs Click here